Atossa Therapeutics Inc. (YAG2) - Financials, balance sheet (annual)

0.75500000 EUR

Last update May 23, 8:11 AM CEST

Market closed

Day range

0.75500000

Previous close

0.75500000

Open

0.75500000

Access this stock data via API

Atossa Therapeutics Inc.

0.76

Financials

Balance sheet

Fiscal date	2024	2022	2021	2020
Total assets	76.4M	123.5M	141.3M	42.8M
Current assets	74.5M	118.2M	141.2M	42.8M
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	71.1M	110.9M	136.4M	39.6M
Other short term investments	—	—	—	—
Accounts receivable	—	—	—	—
Other receivables	—	—	—	—
Inventory	—	—	—	—
Prepaid assets	3.1M	5.2M	2.5M	1.8M
Restricted cash	110K	110K	110K	110K
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	119K	1.2M	1.2M	657K
Non current assets	2.0M	5.3M	22K	69K
Properties	—	—	—	18K
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	36K	186K
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	-16K	-165K
Goodwill	—	—	0	13K
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	13K
Investments and advances	0	4.7M	0	—
Other non current assets	2.0M	635K	22K	17K
Total liabilities	5.0M	5.6M	3.1M	15.7M
Current liabilities	5.0M	5.6M	3.1M	15.7M
Accounts payable	679K	3.0M	1.7M	1.6M
Accrued expenses	1.3M	1.3M	311K	196K
Short term debt	—	—	—	18K
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	1.5M	1.3M	1.1M	861K
Other current liabilities	1.5M	19K	21K	13.0M
Non current liabilities	0	0	0	0
Long term provisions	—	—	—	—
Long term debt	—	—	—	0
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	23.5M	22.8M	22.8M	8.6M
Retained earnings	-211.8M	-156.2M	-129.2M	-111.9M
Other shareholders equity	—	—	—	—
Total shareholders equity	71.5M	118.0M	138.1M	27.2M
Additional paid in capital	261.3M	251.4M	244.6M	130.5M
Treasury stock	1.5M	—	—	—
Minority interest	—	—	—	—